膀胱癌之生物標記及其檢測方法

Translated title of the contribution: Bladder cancer biomarker and its testing method

Yu-Sun Chang (Inventor), Yi-Ting Chen (Inventor), Jau-Song Yu (Inventor), CHIEN-LUN CHEN (Inventor)

Research output: Patent

Abstract

The present invention provides a bladder cancer biomarker and its testing method. The biomarker contains at least one selected from of a group consisting of apolipoprotein A1 (APOA1), apolipoprotein A2 (APOA2), peroxiredoxin 2 (PRDX2), heparin cofactor 2 precursor (HCII), and serum amyloid A-4 protein (SAA4), existed in the urine specimen of a testee. The expression intensity of the biomarker can assist in diagnosing bladder cancer and determining invasion level of cancer cells so as to facilitate understanding of the conditions of patients with bladder cancer, thereby arranging an optimized treatment to achieve the best therapeutic effect.
Translated title of the contributionBladder cancer biomarker and its testing method
Original languageChinese (Traditional)
Patent numberI390204
IPCG01N 33/574(2006.01); G01N 33/68(2006.01)
StatePublished - 21 03 2013

Bibliographical note

公開公告號: I390204
Announcement ID: I390204

Fingerprint

Dive into the research topics of 'Bladder cancer biomarker and its testing method'. Together they form a unique fingerprint.

Cite this